Dr. Lu’s research employs molecular genetic approach to study environmental origins of neuropsychiatric disorders. Trained as a psychiatrist and neuropharmacologist, Dr. Lu completed his postdoctoral training in molecular genetics and was appointed as an Assistant Researcher at Center for Neurobehavioral Genetics of the University of California, Los Angeles (UCLA). Dr. Lu developed the first BAC transgenic Parkinson’s disease (PD) mouse model that recapitulates the cardinal features of PD. His translational study of Huntington’s disease (HD) identified a novel therapeutic strategy (Sci. Transl. Med., 2015; Highlighted in Nat Rev Drug Discov. and was selected as the most influential paper of 2015 by HD insight).   Dr. Lu co-invented a single-cell transgenic technology (MORF, Mosaicism with Repeat Frameshift) that received support from the first round of the Brain Initiative award. Funded by a NARSAD Young Investigator Award, Lu lab generated the next-generation mouse model for schizophrenia (Mol Psychiatry, 2019). Dr. Lu’s lab invented a robust method for efficient and precise CRISPR/Cas9 mediated genome editing in the adult mammalian brain. Dr. Lu is funded by grants from  NIEHS, NASA, NIGMS, and  LSUHS.

PI:  Xiao-Hong Lu, M.D., Ph.D

Associate Professor




Xinli Tian, Ph.D., Postdoctoral scholar
Erika Knott, Postdoctoral Scholar
Mychal S. Grames, Ph.D. Candidate
Kelsea Keys, Research Associate
Hanna Li, Research Associate
Madison Wynne El-Saadi, Ph.D., Now Postdoctoral scholar at UT Health Houston
Adam Richard, Ph.D. student,  Now Study Director at Covince
Michael Ren, Research Associate, Now resident at UAMS Medical Center
Laura Rivers, Medical Student, Now M.D. in internal medicine
Show More
Mychal S. Grames, Ph.D. Candidate